Simplex Trading’s Trinity Biotech TRIB Stock Holding History

Simplex Trading’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-88	Closed	-$18K	–	11405
2021 Q4	$18K	Buy	88 +18	+26%	+$5.1K	﹤0.01%	8495
2021 Q3	$30K	Hold	70	–	–	﹤0.01%	8098
2021 Q2	$30K	Buy	+70	New	+$34.9K	﹤0.01%	8241
2021 Q1	–	Hold	0	–	–	–	7633
2020 Q4	–	Hold	0	–	–	–	7909
2020 Q3	–	Hold	0	–	–	–	7327
2017 Q1	–	Hold	0	–	-$3K	–	6790
2016 Q4	–	Hold	0	–	–	–	4817
2016 Q3	–	Hold	0	–	–	–	5446
2016 Q2	–	Hold	0	–	–	–	4480
2015 Q1	–	Hold	0	–	-$1K	–	5598
2014 Q4	–	Hold	0	–	–	–	4291

Other funds holding TRIB

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Williams & Novak Westlake Village, California $169M AUM 17.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's TRIB Position: Q2 2026 in Review

Simplex Trading reduced its Trinity Biotech (TRIB) stake by 37% in Q2 2026, selling an estimated $130 and leaving 12 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #9081.

Simplex Trading first reported a position in TRIB in Q4 2014 and has held it in 19 quarters since. The position peaked at $28K in Q1 2021. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

Simplex Trading held 12 shares of Trinity Biotech worth $137 as of Q2 2026.
Simplex Trading sold 7 Trinity Biotech shares in Q2 2026, an estimated $130.
Trinity Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #9081 holding.
Simplex Trading first reported a position in Trinity Biotech in Q4 2014 and has held it in 19 quarters since.
Simplex Trading's Trinity Biotech position peaked at $28K in Q1 2021.
19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.